دورية أكاديمية

NRG Oncology/RTOG 0926: Phase II Protocol for Patients With Stage T1 Bladder Cancer to Evaluate Selective Bladder Preserving Treatment by Radiation Therapy Concurrent With Radiosensitizing Chemotherapy Following a Thorough Transurethral Surgical Re-Staging

التفاصيل البيبلوغرافية
العنوان: NRG Oncology/RTOG 0926: Phase II Protocol for Patients With Stage T1 Bladder Cancer to Evaluate Selective Bladder Preserving Treatment by Radiation Therapy Concurrent With Radiosensitizing Chemotherapy Following a Thorough Transurethral Surgical Re-Staging
المؤلفون: Dahl, D.M., Rodgers, J., Shipley, W.U., Michaelson, D., Wu, C.L., Parker, W., Efstathiou, J.A., Jani, A., Cury, F., Hudes, R., Michalski, J.M., Hartford, A.C., Song, D., Citrin, D.E., Karrison, T.G., Feng, F.Y.
المصدر: In International Journal of Radiation Oncology, Biology, Physics 1 November 2021 111(3) Supplement:S133-S134
قاعدة البيانات: ScienceDirect
الوصف
تدمد:03603016
DOI:10.1016/j.ijrobp.2021.07.302